These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11530127)

  • 41. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
    Buyalos RP; Geffner ME; Azziz R; Judd HL
    Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
    Gürlek A; Gedik O
    J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism.
    Tauchmanovà L; Pivonello R; De Martino MC; Rusciano A; De Leo M; Ruosi C; Mainolfi C; Lombardi G; Salvatore M; Colao A
    Eur J Endocrinol; 2007 Sep; 157(3):359-66. PubMed ID: 17766720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discordance in the decline in regional lean and bone mass with advancing age.
    Kuwahata R; Kuwahata T; Iwamoto I; Douchi T
    J Obstet Gynaecol Res; 2005 Dec; 31(6):571-5. PubMed ID: 16343262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.
    Carmina E; Wong L; Chang L; Paulson RJ; Sauer MV; Stanczyk FZ; Lobo RA
    Hum Reprod; 1997 May; 12(5):905-9. PubMed ID: 9194637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex steroids, adiposity and smoking in the pathogenesis of idiopathic hirsutism and polycystic ovary syndrome.
    Byrne B; Cunningham S; Igoe D; Conroy R; McKenna TJ
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):370-4. PubMed ID: 1827700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
    Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High DHEAS/free testosterone ratio is related to better metabolic parameters in women with PCOS.
    Güdücü N; Kutay SS; Görmüş U; Kavak ZN; Dünder İ
    Gynecol Endocrinol; 2015 Jun; 31(6):495-500. PubMed ID: 25986306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome?
    Szydlarska D; Grzesiuk W; Trybuch A; Kondracka A; Kowalik I; Bar-Andziak E
    Endokrynol Pol; 2012; 63(5):356-61. PubMed ID: 23115068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome.
    de Sousa G; Schlüter B; Menke T; Trowitzsch E; Andler W; Reinehr T
    J Sleep Res; 2011 Sep; 20(3):472-8. PubMed ID: 21199038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative contribution of weight-bearing and non-weight-bearing effect of adipose tissue to bone mineral density in postmenopausal women.
    Kawamura Y; Yanazume Y; Kuwahata A; Yonehara Y; Iwamoto I; Tsuji T; Douchi T
    J Obstet Gynaecol Res; 2011 Apr; 37(4):319-24. PubMed ID: 21208341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women.
    Abbasi A; Duthie EH; Sheldahl L; Wilson C; Sasse E; Rudman I; Mattson DE
    J Am Geriatr Soc; 1998 Mar; 46(3):263-73. PubMed ID: 9514370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome.
    Gonzalez F; Thusu K; Abdel-Rahman E; Prabhala A; Tomani M; Dandona P
    Metabolism; 1999 Apr; 48(4):437-41. PubMed ID: 10206434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome?
    Gorkem U; Togrul C; Arslan E; Sargin Oruc A; Buyukkayaci Duman N
    Gynecol Endocrinol; 2018 Feb; 34(2):157-160. PubMed ID: 28933574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.
    Faloia E; Canibus P; Gatti C; Frezza F; Santangelo M; Garrapa GG; Boscaro M
    J Endocrinol Invest; 2004 May; 27(5):424-9. PubMed ID: 15279073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.